MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Change in Directorate
The Board of Directors in their meeting held on August 12, 2021 re-appointed Shri Brijmohan M. Dhoot (DIN:01046420) as a Whole-time Director of the Company for a term of 3 years w.e.f. August 14, 2021, subject to shareholders'' approval being obtained in the ensuing Annual General Meeting. MANGALAM DRUGS & ORGANICS LTD. - 532637 - Un-Audited Financial Results For The Quarter Ended June 30, 2021.
Un-audited Financial Results for the quarter ended June 30, 2021. MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, August 12, 2021.
Outcome of Board Meeting held on Thursday, August 12, 2021. Stocks that are likely to see action today
PowerGrid, Mangalam Drug, Heidelberg, Ashiana Housing in focus Mangalam Drugs & Organics Ltd - 532637 - Intimation Pursuant To Regulation 30 Read With Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Company has entered into a Technology Transfer Agreement with a USD 70 Million leading pharmaceutical company/ group in Nigeria, Africa region, for providing them in-house developed technology. Mangalam Drugs & Organics Ltd - 532637 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, August 12, 2021.
MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 and other applicable provisions, if any, of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, we have to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, August 12, 2021 at the registered office of the Company at Mumbai, inter-alia to consider and approve the Un-Audited Financial Results of the Company for the quarter ended June 30, 2021(Q1). MANGALAM DRUGS & ORGANICS LTD. - 532637 - Updates on Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 03, 2021 for Shree Kishoriju Trading and Investments Pvt Ltd MANGALAM DRUGS & ORGANICS LTD. - 532637 - Updates on Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 03, 2021 for Shree Kishoriju Trading and Investments Pvt Ltd Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 02, 2021 for Shree Kishoriju Trading and Investments Pvt Ltd Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 02, 2021 for Shree Kishoriju Trading and Investment Pvt Ltd